18 October 2017
Alice's Arc co-signs letter to change EU law to force pharmaceutical companies to trial cancer drugs in children
Current EU legislation allows pharma's to use a loophole in EU legislation to avoid trialling cancer drugs in children
Alice's Arc co-signed this letter in conjunction with the Institute of Cancer Research and various other charities to lobby for changes in the current EU legislation to ensure new cancer drugs are used in the treatment of childhood cancers. Since 2012, the current legislation has meant that children have been prevented from trialling 33 new cancer drugs that have come to market. As children's cancers are rare there is little financial incentive for companies to develop drugs for them. The letter attracted a great deal of media interest including The Guardian, The BBC and The Independent.